Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

KNSAKNSA
Showing 8 of 9 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in KINIKSA PHARMACEUTICALS INTL

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds 957,514 shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $61.2M as of 2026-Q2. The position was increased (+7.3% shares). KNSA represents 0.0% of ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's portfolio.

Current Value

$61.2M

Current Shares

957,514

Total Value Change

+$57.2M

Total Shares Change

+795,871

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
957,514
+7.3%
$61.2M0.0%$63.95
32
2026-Q1
Decreased
892,666
-16.4%
$43M0.0%$45.37
0
2025-Q4
Decreased
1.1M
0.0%
$44.1M0.0%$40.99
0
2025-Q3
Increased
1.1M
+45.3%
$41.5M0.0%$38.77
40
2025-Q2
New
735,417
-
$20.3M0.0%$28.04
39
2025-Q1
Exited
0
-100.0%
$00.0%$23.09
0
2024-Q4
Decreased
22,453
-86.1%
$444,1200.0%$19.60
0
2024-Q3
Increased
161,643
+15.4%
$4M0.0%$25.00
31

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used